1naresh

Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1nareshArray
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 1: Patient age group data for enhancing FASI (total) and nonenhancing FASI according to subgroup
Age Group (years) 2–3.9 4–5.9 6–7.9 8–9.9 10–11.9 12–13.9 14–15.9 16–17.9
Participants 5 7 8 15 17 16 13 14
Enhancing FASI 
 Total 0 1 1 7 11 9 9 7
 Splenium of CC 2 5 4 4 2
 Body of CC 1 1 
 Frontal lobe 1 1 1
 Globus pallidus 1 1 1 1^{^a} 1^{^a} 
 Cerebellum 2 4 4 2 + 1^{^a} 3
 Midbrain 0 1 1
Nonenhancing FASI BG and T 
 Total 18 29 39 83 86 54 27 26
 Mean 3.6 4.1 4.9 5.3 5.1 3.4 2.1 1.9
 Range 0–7 1–8 1–10 0–11 1–11 1–10 0–4 0–3
Nonenhancing FASI BS and CB 
 Total 65 85 89 121 141 81 51 62
 Mean 6.5 6.1 5.6 4 4.1 2.3 2 2.2
 Range 0–13 2–12 0–14 0–11 0–9 0–7 1–3 0–8
Nonenhancing FASI splenium CC 
 Total 6 7 5 11 27 35 23 33
 Mean 1.2 1 0.6 0.7 1.6 2.2 1.8 2.4
 Range 0–3 0–3 0–3 0–2 0–5 0–7 1–3 1–6
Nonenhancing FASI remainder CC 
 Total 2 2 1 1 3 3 0 2
 Mean 0.8 0.3 0.1 0.1 0.2 0.2 0 0.1
 Range 0–2 0–1 0–1 0–1 0–1 0–1 0 0–1
Note:—BG indicates basal ganglia; BS, brain stem; CB, cerebellum; CC, corpus callosum; T, thalamus.
↵a Lesions with images not available for volumetric analysis.